NCT Number: NCT00343343
Comparison of NovoFine® Needles (4 mm vs. 6 mm)
This trial is conducted in Europe. The aim of this investigation is to explore the safety of a 4 mm needle compared to a 6 mm needle when injected in children and lean adults with diabetes.
Looking for future studies?
Notify MeKey information
Conditions
Age range
6 year–75 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
Primary location
Novo Nordisk Investigational Site, Aalborg, Denmark
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Children
- Type 1 diabetes
- Insulin treatment for more than ½ year
- BMI lesser than or equal to 19 kg/m2
- Last HbA1c taken within the last year lesser than 10.5%
- Girls: only prepubertal
- Boys: both pre pubertal and pubertal. Adults
- Type 1 and 2 diabetes
- Insulin treatment for more than ½ year
- BMI lesser than or equal to 23 kg/m2
- Last HbA1c taken within the last year lesser than 10.5%
Exclusion criteria
- Known or suspected allergy to trial product(s) or related products.
- Pregnant, breast-feeding or the intention of becoming pregnant or not using adequate contraceptive measures (including country-specific adequate measures, if any).
- Skin disease at abdomen and/or thigh
Treatment and study plan
NovoFine® needle 4 mm
DevicePrimary outcomes
-
Deposition of sterile air depositions.
Secondary outcomes
-
Thickness of 1) dermis and 2) distance from skin surface to muscle fascia
-
Amount of backflow
Sponsors and collaborators
Lead sponsor
Novo Nordisk A/S
Industry
Registry information
Official study title
A Comparative, Randomised Study With NovoFine® 4 mm Needle Versus NovoFine® 6 mm Needle in Regard to Anatomical Deposition of Sterile Air in Children and Thin Adults With Diabetes and Backflow of Test Medium (Only Adults) After Injection in Thigh and Abdomen
Important dates
- Study start
- 2006
- Primary completion
- 2006
- Study completion
- 2006
- First posted
- Jun 22, 2006
- Registry last updated
- Feb 8, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics
NCT00773279
Autoimmune Diseases, Delivery Systems
Burlingame, California, United States
View Trial DetailsInvestigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations
NCT01680328
Autoimmune Diseases, Delivery Systems
Neuss, Germany
View Trial DetailsLocalisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long Needles
NCT00871416
Autoimmune Diseases, Delivery Systems
Aarhus, Denmark
View Trial DetailsComparison of Two Pen Systems in Patients With Diabetes Treated With Insulin
NCT00569998
Autoimmune Diseases, Delivery Systems
Vienna, Austria
View Trial Details